MONZA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 5.031
EU - Europa 2.606
AS - Asia 931
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
SA - Sud America 2
Totale 8.584
Nazione #
US - Stati Uniti d'America 4.959
IT - Italia 680
DE - Germania 593
CN - Cina 551
SE - Svezia 445
IE - Irlanda 309
GB - Regno Unito 158
HK - Hong Kong 117
VN - Vietnam 115
UA - Ucraina 93
RU - Federazione Russa 73
CA - Canada 72
DK - Danimarca 67
FR - Francia 54
IN - India 47
TR - Turchia 44
FI - Finlandia 33
AT - Austria 29
BE - Belgio 20
JP - Giappone 16
NL - Olanda 13
SG - Singapore 13
KR - Corea 12
ES - Italia 7
IR - Iran 7
HR - Croazia 6
AU - Australia 5
EU - Europa 5
RO - Romania 5
ID - Indonesia 4
PT - Portogallo 4
RS - Serbia 4
BG - Bulgaria 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
SC - Seychelles 3
PL - Polonia 2
TW - Taiwan 2
BR - Brasile 1
CL - Cile 1
IL - Israele 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 8.584
Città #
Ann Arbor 1.890
Frankfurt am Main 455
Wilmington 367
Chandler 358
Woodbridge 314
Dublin 299
Milan 293
Dearborn 246
Fairfield 213
Ashburn 203
Houston 180
New York 174
Princeton 140
Hong Kong 114
Nanjing 114
Jacksonville 103
Seattle 93
Cambridge 65
Guangzhou 57
Shanghai 55
Dong Ket 49
Nanchang 38
Boardman 36
Lawrence 33
Altamura 32
Shenyang 29
Vienna 29
Hangzhou 26
Pune 25
Toronto 22
Beijing 21
Shangdi 21
Los Angeles 20
Ottawa 20
Zhengzhou 20
Andover 19
Kunming 19
Carate Brianza 18
San Diego 18
Brussels 17
Kocaeli 17
Sacramento 16
Falls Church 15
Rome 15
Tianjin 15
Jiaxing 14
Jinan 14
Edmonton 13
Fremont 13
Hebei 13
Lachine 13
Changsha 12
Helsinki 12
Lissone 12
Mainz 12
Norwalk 12
Codroipo 10
London 10
Kiev 9
Sesto San Giovanni 8
Hefei 7
Wuhan 7
Frederick 6
Grafing 6
Induno Olona 6
Taizhou 6
Chengdu 5
Falkenstein 5
Lanzhou 5
Merate 5
Ningbo 5
Paderno Dugnano 5
Pavia 5
Tokyo 5
Villeurbanne 5
Washington 5
Zagreb 5
Bologna 4
Cagliari 4
Cislago 4
Council Bluffs 4
Duncan 4
Haikou 4
Lappeenranta 4
Laurel 4
Leawood 4
Lyon 4
Perugia 4
San Mateo 4
Tacoma 4
Anyang-si 3
Barneveld 3
Bergamo 3
Chicago 3
Daejeon 3
Forest Hills 3
Genova 3
Gijang-gun 3
Huizen 3
Legnano 3
Totale 6.675
Nome #
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 280
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 273
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 207
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 201
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 198
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 196
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 193
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 192
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 190
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 188
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 185
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 178
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 174
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 172
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 168
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 166
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 165
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 164
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 162
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 161
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 161
In vitro models for studying oxaliplatin neurotoxic effects 155
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 152
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 150
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 144
Incubation with low doses of oxaliplatin modifies the electrophysiological properties of dorsal root ganglion neurons 138
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 134
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 132
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 132
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 131
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 130
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 130
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 129
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 124
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 123
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 121
Thermal plantar test in experimental ischemic stroke 118
Multimodal experimental approach to the study of human neurological diseases 118
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 118
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 115
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 115
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 114
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 110
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 110
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 109
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 107
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 106
Pharmacokinetics of IVIg in Wistar rats 104
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 101
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 100
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 97
An in vitro model of dorsal root ganglion (DRG) neurons to investigate the molecular mechanisms of oxaliplatin-induced peripheral neuropathy. 91
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 90
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 89
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 88
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 88
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 87
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 87
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 80
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 78
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 77
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 77
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 77
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 73
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 71
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 67
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 64
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 63
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 62
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 57
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 52
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 49
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 45
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 45
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 43
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 22
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 3
Totale 9.366
Categoria #
all - tutte 25.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019192 0 0 0 0 0 0 0 0 0 0 69 123
2019/20201.577 188 96 100 105 132 216 239 106 117 148 110 20
2020/20212.161 48 59 222 210 155 226 249 254 179 160 161 238
2021/20221.207 122 164 133 116 84 96 60 54 49 63 84 182
2022/20231.825 198 362 223 187 155 304 58 84 120 31 64 39
2023/20241.026 55 46 58 76 144 288 189 75 63 32 0 0
Totale 9.366